Français
ItalianoBond Gilead Medica 3.5% ( US375558AZ68 ) in USD
| Issuer | Gilead Medica |
| Market price | 100 % ▲ |
| Country |  United States
|
| ISIN code |
 US375558AZ68 ( in USD )
|
| Interest rate | 3.5% per year ( payment 2 times a year) |
| Maturity | 01/02/2025 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 750 000 000 USD |
| Cusip | 375558AZ6 |
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. Gilead Sciences' US$1,750,000,000 3.5% bonds (CUSIP: 375558AZ6, ISIN: US375558AZ68), maturing February 1, 2025, currently trade at 100% of par value, paying semi-annual interest, with a minimum purchase size of 2,000 bonds, and are rated BBB+ by S&P and A3 by Moody's. |